Elicio Therapeutics Q3 EPS $(0.30) Beats $(0.43) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Elicio Therapeutics (NASDAQ:ELTX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.43) by 30.23 percent. This is a 50 percent increase over losses of $(0.60) per share from
Elicio Therapeutics (NASDAQ:ELTX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.43) by 30.23 percent. This is a 50 percent increase over losses of $(0.60) per share from the same period last year.